Centaur Pharma Warning Letter June 2023 USFDA | Learning from Warning Letter

Centaur Pharmaceuticals Ambernath received a Warning Letter from USFDA in June 2023 for the inspection conducted in Nov-2022.
The observations cited include control on document issuance and control by Quality Unit and equipment cleaning.
Your Queries:
USFDA Warning Letters 2023
Warning Letters
USFDA Observation
Centaur Warning Letter
#usfda #USFDA483 #USFDAInspectionObservations #pharmaceutical #pharmaceuticalcompanies
About the Channel:
The channel provides details of pharmaceutical guidelines, important updates on pharmaceuticals and other professional topics like interview preparation, personality development etc.
Contact us at:
[e-mail]
/ proftalks1680
/ 13995930
Subscribe to our channel for more informative videos: / @proftalks1680

[@pavansawant]

thanks for your explanation sir.

[@proftalks1680]

Thanks🙏